OODA REASSESSMENT | November 11, 2026
NVIDIA has fallen sharply, and the valuation looks more attractive. But price alone does not settle the question. The business is still growing at remarkable speed; technical damage and unresolved questions about leadership and governance raise the risk attached to that growth.
Why the buy zones moved lower: Compared with the November 5 ranges, these updated zones require a larger discount because the board investigation added uncertainty and NVDA broke below key moving averages and near-term support. NVIDIA’s latest reported fundamentals were still strong, so the lower ranges reflect a more cautious margin of safety while possible negative developments remain unresolved—not a finding that the business itself had suddenly weakened or that fair value fell by the same amount.
We don’t know what the unknown holds. Until we do, the OODA loop expects volatility.
Current decision: Watch around $178 premarket. A small starter may be reasonable in the $165–175 zone after stabilization. Avoid treating the selloff as an automatic buy signal.
Price snapshot
As of November 11 before the opening bell, the last completed regular-session close was $168.89 on November 10. A retrieved premarket quote was $177.84 at 5:46 a.m. ET. Premarket prices move quickly. The 52-week high is $243.37 and the 52-week low is approximately $164–166, depending on the data provider.
From the regular-session close, NVDA was 30.6% below its 52-week high. At the retrieved premarket quote, it was 26.9% below that high. The correction formula is (current price − 52-week high) ÷ 52-week high.
What changed in the thesis?
The fall reflects both broad pressure on AI-related shares and a company-specific governance issue. NVIDIA’s board opened an independent investigation after reports that CEO Jensen Huang had been targeted by a foreign intelligence effort. The board said it had no reason to believe national security or company secrets were compromised, and later retained outside counsel. The inquiry’s outcome is unknown; allegations are not findings.
The relative move suggests the company-specific issue matters. On November 9 NVDA fell 4.27% while the semiconductor ETF SOXX rose 7.49%. On November 10 NVDA fell 5.47%, while SOXX was nearly flat. This relative weakness means the decline cannot be explained solely by sector selling. A November 11 premarket recovery followed CoreWeave results that eased some AI-spending fears, but a bounce does not resolve NVIDIA’s governance uncertainty.
Fundamentals: strong results, next test ahead
NVIDIA’s latest reported quarter, Q2 FY2027 ended July 26, showed revenue of $96.2 billion, up 106% year over year and 18% sequentially. Data Center revenue was $89.0 billion, up 117%. Gross margin was 75%; GAAP diluted EPS was $2.46 and non-GAAP diluted EPS was $2.22.
For Q3, management guided to $108 billion in revenue, plus or minus 2%, and a 74% gross margin, plus or minus 0.5 percentage point. The outlook assumed no Data Center compute revenue from China. Q3 results are scheduled for November 17 after market close. The critical details will be forward guidance, margin direction, cash collection, supply constraints, and management’s response to governance questions.
The balance sheet remained strong in the latest filing: cash and marketable debt securities were about $56.6 billion against $33.4 billion of debt. First-half operating cash flow was $74.4 billion; subtracting $4.4 billion of capital and intangible purchases gives roughly $70.0 billion of simple free cash flow. However, receivables and inventory rose, and supply commitments reached $279 billion. These commitments represent capacity and component procurement, not customer backlog. Customer concentration is also material.
Business condition: operating results were strengthening in the latest quarter. The main near-term deterioration is uncertainty around governance and the market’s willingness to finance AI infrastructure, not yet a demonstrated collapse in product demand.
Valuation: a discount, with assumptions attached
Published forward P/E estimates conflict: one data provider shows 13.94×, while reporting based on FactSet cited 11.66×. Their forecast periods and adjustments were not reconciled, so I do not use either as the only valuation anchor.
A transparent cross-check: Q2 non-GAAP EPS of $2.22 annualized equals $8.88. At the November 10 close, that is about 19× the annualized quarterly run rate; at $177.84 it is about 20×. This is an annualization, not a forecast. Annualizing first-half simple free cash flow produces about $140 billion, or an estimated 3.4% FCF yield at the closing market value. The yield is attractive relative to a high-growth company’s prior valuation, but it still assumes cash generation holds up.
For the zones below, the valuation reference uses $10 of adjusted annual EPS as a base case, $8 in a stress case, and $12 in a strong-growth case. These are scenario inputs, not company guidance. At $168.89, the base case implies approximately 16.9× earnings; at $177.84, approximately 17.8×. Lower valuation does not remove the risk that earnings estimates themselves may fall.
Technical picture: oversold, trend still damaged
On November 10, NVDA closed well below the 20-day average near $206, the 50-day near $218, and the 200-day near $205. Its 14-day RSI was reported near 24, a deeply oversold reading. Volume was about 429 million shares, roughly 2.8 times the cited 20-day average. That signals heavy turnover, but does not reveal who was selling.
Near-term support is around $164–166, close to the 52-week low. Initial resistance sits around $175–180, followed by the $180–187 breakdown area. The $200–206 moving-average cluster and $218–220 50-day average are larger resistance zones. Price action has made lower highs and lows; an oversold bounce is possible, but a bottom is not confirmed. A higher low and a successful retest would improve the setup.
Updated buy and trim zones
- $220 and above — No New Buys / consider trim: near the declining 50-day average and overhead supply. At $220, price equals 22× the $10 adjusted EPS base assumption. Reassess if a fast rebound reaches this area without confirming evidence.
- $175–220 — Watch: resistance stacks from the short-term breakdown area through the $200–206 moving-average cluster and $218–220 50-day average. Risk/reward is less compelling near the top of the range.
- $165–175 — Starter: near annual-low support and equal to 16.5–17.5× the $10 base EPS assumption. Consider only a small initial position after stabilization.
- $150–165 — Accumulation: 15–16.5× base EPS, with a larger margin of safety. A break below annual support should be investigated before adding.
- $135–150 — High Conviction, conditional: 13.5–15× base EPS. The label applies only if demand remains intact, margins hold, and governance uncertainty recedes. Those conditions are not established today.
- Below $135 — Exceptional / reassess: rebuild the earnings and governance case. Even at $135, a stress assumption of $8 EPS implies about 17× earnings; a lower price by itself does not make the shares exceptional value.
The $164–175 boundaries are anchored mainly to nearby support and price structure. The $200–220 boundaries reflect moving-average resistance and the valuation base. The $150 and $135 levels are valuation thresholds, not verified historical support.
Market, sector, and flows
The market backdrop is mixed to defensive. On November 10, the S&P 500 fell 0.4% and Nasdaq fell 0.7%, though both were still up about 2% for the week. October CPI rose 0.4% month over month; core CPI rose 0.3%. The Federal Reserve held rates at 3.75%–4.00% in October, with two members preferring a quarter-point increase. Higher yields and persistent inflation pressure long-duration growth valuations.
AI infrastructure spending remains large. Microsoft reported $45.2 billion of quarterly capital expenditure and expected more than $50 billion next quarter; delivery timing shifted some spending. This supports ongoing demand across the ecosystem but does not guarantee NVIDIA captures all of it.
NVIDIA repurchased $19.7 billion of stock in Q2. Authorization and historic repurchases do not prove ongoing support at a given price. Available short-interest data are lagged and modest as a share of the float; there is no basis to attribute the selloff mainly to short sellers. Current institutional selling, options positioning, and ETF flows were not independently verified.
Seasonality does not drive this decision. The November 17 earnings report and investigation updates matter more than a calendar pattern.
Catalysts and risks
Catalysts: Q3 results beating guidance with strong forward demand; Vera Rubin shipments converting into revenue; continued hyperscaler investment; improved cash collections; and a credible resolution of governance questions.
Risks: damaging investigation findings or leadership disruption; tighter export restrictions; customer financing stress; competition and custom silicon; supply commitments outrunning realized demand; margin erosion; and higher interest rates.
Pause buying and rebuild the thesis if the investigation reveals material compliance failures or operational disruption, guidance signals a sustained demand reset, margins deteriorate persistently, or receivables and inventory grow faster than collections. A sustained, high-volume break below $164 invalidates the immediate support setup, though it does not alone prove the long-term business thesis broken.
Scenario returns and confidence
At $168.89, the bear case of $120 implies about 29% downside, the base case of $240 implies 42% upside, and the bull case of $330 implies 95% upside. At the retrieved $177.84 premarket quote, the base-case upside falls to about 35%, while downside to $120 grows to about 33%. The base-case upside/downside ratio falls from roughly 1.45:1 at the close to about 1.08:1 premarket.
No probabilities are assigned because the investigation’s outcome and potential financial consequences cannot be estimated credibly from available evidence. Confidence is moderate in the watch/small-starter decision and low to moderate in the lower zone boundaries. Strong results and balance-sheet capacity support the thesis; unresolved governance questions, unconfirmed technical stabilization, conflicting forward-EPS estimates, and incomplete peer and flow data limit confidence.
OODA decision
Observe: NVDA closed 30.6% below its 52-week high and bounced premarket. Latest reported operating results remained exceptionally strong.
Orient: The stock is cheaper, but its trend is damaged and governance uncertainty adds a company-specific risk premium.
Decide: Watch near $178. A small starter in $165–175 is reasonable only after stabilization and if position sizing can tolerate the bear case. Keep meaningful accumulation conditional on earnings and investigation evidence.
Act: Do not chase the premarket rebound. For an existing position, hold only a size consistent with the potential downside and review concentration before adding. Reassess after November 17 earnings or material investigation findings.
Related OBORDA reading
- NVDA Stock Reassessment: 5 Signals Behind My Buying Plan — the November 5 analysis that preceded this reassessment.
- What the Six OODA Buy Zones Mean — a plain-English guide to the six levels used in this analysis.

